|
|
|
Insider
Information: |
Bailey Don M |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
699,357 |
|
Indirect Shares
|
329,463 |
|
|
Direct
Value |
$4,491,463 |
|
|
Indirect Value
|
$812,858 |
|
|
Total
Shares |
1,028,820 |
|
|
Total
Value |
$5,304,321 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Comarco Inc |
CMRO |
Chairman of the Board,... |
2006-02-06 |
64,188 |
2007-03-21 |
66,859 |
Premium* |
|
STAAR Surgical Co |
STAA |
Director |
2013-05-15 |
98,137 |
2008-11-14 |
15,000 |
Premium* |
|
Questcor Pharmaceuticals Inc |
QCOR |
See Remarks, Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Mallinckrodt plc |
MNK |
Director |
2016-03-16 |
139,149 |
2014-09-08 |
88,803 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-05-13 |
88,235 |
2016-05-13 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
Director |
2016-08-29 |
247,001 |
|
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2019-03-08 |
62,647 |
2024-02-08 |
158,801 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
129 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2013-02-19 |
4 |
OE |
$5.09 |
$181,204 |
I/I |
35,600 |
134,600 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2015-02-13 |
4 |
AS |
$114.20 |
$3,884,958 |
D/D |
(33,891) |
136,605 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2015-03-13 |
4 |
AS |
$122.89 |
$4,936,142 |
D/D |
(40,000) |
136,605 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-08-27 |
4 |
OE |
$5.09 |
$203,600 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-09-13 |
4 |
OE |
$5.09 |
$203,600 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-06-13 |
4 |
OE |
$5.09 |
$203,600 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-09-13 |
4 |
OE |
$5.10 |
$204,000 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-10-14 |
4 |
OE |
$5.10 |
$204,000 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-11-13 |
4 |
OE |
$5.10 |
$204,000 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-12-13 |
4 |
OE |
$5.10 |
$204,000 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-01-13 |
4 |
OE |
$5.10 |
$204,000 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-02-13 |
4 |
OE |
$5.10 |
$204,400 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-03-13 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-04-14 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-05-13 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-06-13 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
|
2014-07-14 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2016-03-16 |
4 |
D |
$55.69 |
$25,506 |
D/D |
(458) |
139,149 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
PRESIDENT & CEO |
|
2008-05-30 |
4 |
A |
$0.48 |
$19,380 |
D/D |
40,000 |
139,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2008-11-06 |
4/A |
OE |
$8.75 |
$1,687,481 |
D/D |
192,855 |
139,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2008-11-07 |
4/A |
OE |
$8.51 |
$1,266,949 |
D/D |
148,806 |
139,500 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2015-03-19 |
4 |
D |
$131.21 |
$79,513 |
D/D |
(606) |
139,607 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2015-04-13 |
4 |
AS |
$127.31 |
$5,104,283 |
D/D |
(40,000) |
139,607 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2015-05-13 |
4 |
AS |
$122.43 |
$6,296,033 |
D/D |
(51,417) |
139,607 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2015-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,608 |
140,213 |
0 |
- |
|
129 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|